E-CURD-116	A-AFFY-45	GSM303303	characteristic	age	6 to 8 week
E-CURD-116	A-AFFY-45	GSM303303	characteristic	developmental stage	adult	http://www.ebi.ac.uk/efo/EFO_0001272
E-CURD-116	A-AFFY-45	GSM303303	characteristic	disease	pancreatic carcinoma	http://www.ebi.ac.uk/efo/EFO_0002618
E-CURD-116	A-AFFY-45	GSM303303	characteristic	organism	Mus musculus	http://purl.obolibrary.org/obo/NCBITaxon_10090
E-CURD-116	A-AFFY-45	GSM303303	characteristic	organism part	subcutaneous tissue
E-CURD-116	A-AFFY-45	GSM303303	characteristic	sampling site	neoplasm	http://www.ebi.ac.uk/efo/EFO_0000616
E-CURD-116	A-AFFY-45	GSM303303	characteristic	sex	female	http://purl.obolibrary.org/obo/PATO_0000383
E-CURD-116	A-AFFY-45	GSM303303	characteristic	strain	nu/nu
E-CURD-116	A-AFFY-45	GSM303303	characteristic	xenograft	mixed  HT-29, HT55 and DLD-1 subcutaneous injection until neoplasm formation
E-CURD-116	A-AFFY-45	GSM303303	factor	compound	none	http://www.ebi.ac.uk/efo/EFO_0001461
E-CURD-116	A-AFFY-45	GSM303304	characteristic	age	6 to 8 week
E-CURD-116	A-AFFY-45	GSM303304	characteristic	developmental stage	adult	http://www.ebi.ac.uk/efo/EFO_0001272
E-CURD-116	A-AFFY-45	GSM303304	characteristic	disease	pancreatic carcinoma	http://www.ebi.ac.uk/efo/EFO_0002618
E-CURD-116	A-AFFY-45	GSM303304	characteristic	organism	Mus musculus	http://purl.obolibrary.org/obo/NCBITaxon_10090
E-CURD-116	A-AFFY-45	GSM303304	characteristic	organism part	subcutaneous tissue
E-CURD-116	A-AFFY-45	GSM303304	characteristic	sampling site	neoplasm	http://www.ebi.ac.uk/efo/EFO_0000616
E-CURD-116	A-AFFY-45	GSM303304	characteristic	sex	female	http://purl.obolibrary.org/obo/PATO_0000383
E-CURD-116	A-AFFY-45	GSM303304	characteristic	strain	nu/nu
E-CURD-116	A-AFFY-45	GSM303304	characteristic	xenograft	mixed  HT-29, HT55 and DLD-1 subcutaneous injection until neoplasm formation
E-CURD-116	A-AFFY-45	GSM303304	factor	compound	none	http://www.ebi.ac.uk/efo/EFO_0001461
E-CURD-116	A-AFFY-45	GSM303305	characteristic	age	6 to 8 week
E-CURD-116	A-AFFY-45	GSM303305	characteristic	developmental stage	adult	http://www.ebi.ac.uk/efo/EFO_0001272
E-CURD-116	A-AFFY-45	GSM303305	characteristic	disease	pancreatic carcinoma	http://www.ebi.ac.uk/efo/EFO_0002618
E-CURD-116	A-AFFY-45	GSM303305	characteristic	organism	Mus musculus	http://purl.obolibrary.org/obo/NCBITaxon_10090
E-CURD-116	A-AFFY-45	GSM303305	characteristic	organism part	subcutaneous tissue
E-CURD-116	A-AFFY-45	GSM303305	characteristic	sampling site	neoplasm	http://www.ebi.ac.uk/efo/EFO_0000616
E-CURD-116	A-AFFY-45	GSM303305	characteristic	sex	female	http://purl.obolibrary.org/obo/PATO_0000383
E-CURD-116	A-AFFY-45	GSM303305	characteristic	strain	nu/nu
E-CURD-116	A-AFFY-45	GSM303305	characteristic	xenograft	mixed  HT-29, HT55 and DLD-1 subcutaneous injection until neoplasm formation
E-CURD-116	A-AFFY-45	GSM303305	factor	compound	none	http://www.ebi.ac.uk/efo/EFO_0001461
E-CURD-116	A-AFFY-45	GSM303306	characteristic	age	6 to 8 week
E-CURD-116	A-AFFY-45	GSM303306	characteristic	developmental stage	adult	http://www.ebi.ac.uk/efo/EFO_0001272
E-CURD-116	A-AFFY-45	GSM303306	characteristic	disease	pancreatic carcinoma	http://www.ebi.ac.uk/efo/EFO_0002618
E-CURD-116	A-AFFY-45	GSM303306	characteristic	organism	Mus musculus	http://purl.obolibrary.org/obo/NCBITaxon_10090
E-CURD-116	A-AFFY-45	GSM303306	characteristic	organism part	subcutaneous tissue
E-CURD-116	A-AFFY-45	GSM303306	characteristic	sampling site	neoplasm	http://www.ebi.ac.uk/efo/EFO_0000616
E-CURD-116	A-AFFY-45	GSM303306	characteristic	sex	female	http://purl.obolibrary.org/obo/PATO_0000383
E-CURD-116	A-AFFY-45	GSM303306	characteristic	strain	nu/nu
E-CURD-116	A-AFFY-45	GSM303306	characteristic	xenograft	mixed  HT-29, HT55 and DLD-1 subcutaneous injection until neoplasm formation
E-CURD-116	A-AFFY-45	GSM303306	factor	compound	none	http://www.ebi.ac.uk/efo/EFO_0001461
E-CURD-116	A-AFFY-45	GSM303307	characteristic	age	6 to 8 week
E-CURD-116	A-AFFY-45	GSM303307	characteristic	developmental stage	adult	http://www.ebi.ac.uk/efo/EFO_0001272
E-CURD-116	A-AFFY-45	GSM303307	characteristic	disease	pancreatic carcinoma	http://www.ebi.ac.uk/efo/EFO_0002618
E-CURD-116	A-AFFY-45	GSM303307	characteristic	organism	Mus musculus	http://purl.obolibrary.org/obo/NCBITaxon_10090
E-CURD-116	A-AFFY-45	GSM303307	characteristic	organism part	subcutaneous tissue
E-CURD-116	A-AFFY-45	GSM303307	characteristic	sampling site	neoplasm	http://www.ebi.ac.uk/efo/EFO_0000616
E-CURD-116	A-AFFY-45	GSM303307	characteristic	sex	female	http://purl.obolibrary.org/obo/PATO_0000383
E-CURD-116	A-AFFY-45	GSM303307	characteristic	strain	nu/nu
E-CURD-116	A-AFFY-45	GSM303307	characteristic	xenograft	mixed  HT-29, HT55 and DLD-1 subcutaneous injection until neoplasm formation
E-CURD-116	A-AFFY-45	GSM303307	factor	compound	HhAntag
E-CURD-116	A-AFFY-45	GSM303307	factor	dose	75 milligram per kilogram
E-CURD-116	A-AFFY-45	GSM303308	characteristic	age	6 to 8 week
E-CURD-116	A-AFFY-45	GSM303308	characteristic	developmental stage	adult	http://www.ebi.ac.uk/efo/EFO_0001272
E-CURD-116	A-AFFY-45	GSM303308	characteristic	disease	pancreatic carcinoma	http://www.ebi.ac.uk/efo/EFO_0002618
E-CURD-116	A-AFFY-45	GSM303308	characteristic	organism	Mus musculus	http://purl.obolibrary.org/obo/NCBITaxon_10090
E-CURD-116	A-AFFY-45	GSM303308	characteristic	organism part	subcutaneous tissue
E-CURD-116	A-AFFY-45	GSM303308	characteristic	sampling site	neoplasm	http://www.ebi.ac.uk/efo/EFO_0000616
E-CURD-116	A-AFFY-45	GSM303308	characteristic	sex	female	http://purl.obolibrary.org/obo/PATO_0000383
E-CURD-116	A-AFFY-45	GSM303308	characteristic	strain	nu/nu
E-CURD-116	A-AFFY-45	GSM303308	characteristic	xenograft	mixed  HT-29, HT55 and DLD-1 subcutaneous injection until neoplasm formation
E-CURD-116	A-AFFY-45	GSM303308	factor	compound	HhAntag
E-CURD-116	A-AFFY-45	GSM303308	factor	dose	75 milligram per kilogram
E-CURD-116	A-AFFY-45	GSM303309	characteristic	age	6 to 8 week
E-CURD-116	A-AFFY-45	GSM303309	characteristic	developmental stage	adult	http://www.ebi.ac.uk/efo/EFO_0001272
E-CURD-116	A-AFFY-45	GSM303309	characteristic	disease	pancreatic carcinoma	http://www.ebi.ac.uk/efo/EFO_0002618
E-CURD-116	A-AFFY-45	GSM303309	characteristic	organism	Mus musculus	http://purl.obolibrary.org/obo/NCBITaxon_10090
E-CURD-116	A-AFFY-45	GSM303309	characteristic	organism part	subcutaneous tissue
E-CURD-116	A-AFFY-45	GSM303309	characteristic	sampling site	neoplasm	http://www.ebi.ac.uk/efo/EFO_0000616
E-CURD-116	A-AFFY-45	GSM303309	characteristic	sex	female	http://purl.obolibrary.org/obo/PATO_0000383
E-CURD-116	A-AFFY-45	GSM303309	characteristic	strain	nu/nu
E-CURD-116	A-AFFY-45	GSM303309	characteristic	xenograft	mixed  HT-29, HT55 and DLD-1 subcutaneous injection until neoplasm formation
E-CURD-116	A-AFFY-45	GSM303309	factor	compound	HhAntag
E-CURD-116	A-AFFY-45	GSM303309	factor	dose	75 milligram per kilogram
E-CURD-116	A-AFFY-45	GSM303310	characteristic	age	6 to 8 week
E-CURD-116	A-AFFY-45	GSM303310	characteristic	developmental stage	adult	http://www.ebi.ac.uk/efo/EFO_0001272
E-CURD-116	A-AFFY-45	GSM303310	characteristic	disease	pancreatic carcinoma	http://www.ebi.ac.uk/efo/EFO_0002618
E-CURD-116	A-AFFY-45	GSM303310	characteristic	organism	Mus musculus	http://purl.obolibrary.org/obo/NCBITaxon_10090
E-CURD-116	A-AFFY-45	GSM303310	characteristic	organism part	subcutaneous tissue
E-CURD-116	A-AFFY-45	GSM303310	characteristic	sampling site	neoplasm	http://www.ebi.ac.uk/efo/EFO_0000616
E-CURD-116	A-AFFY-45	GSM303310	characteristic	sex	female	http://purl.obolibrary.org/obo/PATO_0000383
E-CURD-116	A-AFFY-45	GSM303310	characteristic	strain	nu/nu
E-CURD-116	A-AFFY-45	GSM303310	characteristic	xenograft	mixed  HT-29, HT55 and DLD-1 subcutaneous injection until neoplasm formation
E-CURD-116	A-AFFY-45	GSM303310	factor	compound	HhAntag
E-CURD-116	A-AFFY-45	GSM303310	factor	dose	75 milligram per kilogram
